Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 25, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

Synthetic 3D multicellular systems for drug development.

Markus Rimann1, Ursula Graf-Hausner

  • 1Zurich University of Applied Sciences, Institute of Chemistry and Biological Chemistry, Einsiedlerstr. 31, 8820 Wädenswil, Switzerland.

Current Opinion in Biotechnology
|February 14, 2012
PubMed
Summary

Three dimensional (3D) cell culture offers greater biological relevance than traditional two dimensional (2D) methods. Advancements are making 3D systems increasingly viable for industrial applications like drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acrylonitrile and Pullulan Based Nanofiber Mats as Easily Accessible Scaffolds for 3D Skin Cell Models Containing Primary Cells.

Cells·2022
Same author

Cross-industrial applications of organotypic models.

ALTEX·2022
Same author

Matrigel 3D bioprinting of contractile human skeletal muscle models recapitulating exercise and pharmacological responses.

Communications biology·2021
Same author

Swiss-Chinese cooperation for organs-on-a-chip and stem cell research.

ALTEX·2020
Same author

TEDD Competence Centre Report 2019.

Chimia·2020
Same author

Advanced in vitro models analysis.

ALTEX·2019

Area of Science:

  • Biotechnology
  • Cell Biology
  • Drug Discovery

Background:

  • Two dimensional (2D) cell culture has limitations in mimicking in vivo environments.
  • Three dimensional (3D) cell culture systems offer enhanced biological relevance.
  • Despite academic adoption, 2D cultures persist in industrial efficacy and toxicology testing.

Purpose of the Study:

  • To highlight the growing importance of 3D cell culture systems.
  • To discuss the transition from 2D to 3D cell culture in industrial settings.
  • To identify key factors for the broader adoption of 3D cell culture.

Main Methods:

  • Review of current trends in cell culture technology.
  • Analysis of the challenges and opportunities in transitioning to 3D systems.

More Related Videos

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
09:58

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing

Published on: April 23, 2015

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
08:34

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

Related Experiment Videos

Last Updated: May 25, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
09:58

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing

Published on: April 23, 2015

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
08:34

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

  • Discussion of innovations enabling biological relevance, reproducibility, and high throughput.

    • Main Results:

    • 3D cell culture is increasingly utilized in academic research.
    • Significant barriers remain for widespread industrial adoption of 3D systems.
    • Technological advancements are addressing the need for cost-effectiveness and scalability.

    Conclusions:

    • The shift from 2D to 3D cell culture for industrial applications, particularly drug development, is inevitable.
    • Ensuring biological relevance, reproducibility, and high throughput at acceptable costs are critical for 3D system adoption.
    • Ongoing innovations are paving the way for the future of 3D cell culture in industry.